Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 17, 2025Sep 17 2:20 PMCarroll Patrick Harrison
Proposed Sale
10,021$50.50$506.1K—

View →

Sep 17, 2025Sep 17 2:07 PMChi Michael
Proposed Sale
13,749$50.50$694.3K—

View →

Sep 17, 2025Sep 17 1:50 PMBecklund Irene
Proposed Sale
8,410$50.50$424.7K—

View →

Sep 16, 2025Sep 16 3:29 PMDudum Andrew
Proposed Sale
175,661$53.42$9.4M—

View →

Sep 15, 2025Sep 15 10:35 PMOluyemi Okupe
Proposed Sale
145,000$53.96$7.8M—

View →

Sep 15, 2025Sep 15 3:49 PMChi Michael
Proposed Sale
4,150$56.00$232.4K—

View →

Aug 25, 2025Aug 25 1:46 PMBoughton Soleil
Proposed Sale
2,571$44.53$114.5K—

View →

Aug 18, 2025Aug 18 4:33 PMDudum Andrew
Proposed Sale
47,534$45.05$2.1M—

View →

Aug 18, 2025Aug 18 2:22 PMDudum Andrew
Proposed Sale
128,127$45.22$5.8M—

View →

Aug 12, 2025Aug 12 9:22 PMMelissa Baird
Proposed Sale
33,333$47.96$1.6M—

View →

Aug 11, 2025Aug 11 2:18 PMBoughton Soleil
Proposed Sale
2,572$51.64$132.8K—

View →

Aug 6, 2025Aug 6 5:27 PMCarroll Patrick Harrison
Proposed Sale
60,000$53.58$3.2M—

View →

Aug 1, 2025Aug 1 3:12 PMChi Michael
Proposed Sale
250$64.44$16.1K—

View →

Jul 31, 2025Jul 31 3:02 PMChi Michael
Proposed Sale
26,350$67.00$1.8M—

View →

Jul 28, 2025Jul 28 4:59 PMBoughton Soleil
Proposed Sale
2,572$58.70$151.0K—

View →

Jul 24, 2025Jul 24 2:44 PMChi Michael
Proposed Sale
2,100$57.52$120.8K—

View →

Jul 23, 2025Jul 23 4:19 PMChi Michael
Proposed Sale
13,750$56.00$770.0K—

View →

Jul 21, 2025Jul 21 8:59 PMMelissa Baird
Proposed Sale
33,333$47.60$1.6M—

View →

Jul 21, 2025Jul 21 2:41 PMDudum Andrew
Proposed Sale
125,335$49.54$6.2M—

View →

Jul 16, 2025Jul 16 3:49 PMDudum Andrew
Proposed Sale
50,326$50.27$2.5M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,987—16,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369—229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,421—74,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200—137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,076—62,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711—526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489—150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111—188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844—413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978—300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 4 of 4